Nebulum Technologies Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Nebulum’s flagship offering is its 3D Whole-Tissue Imaging service, which encompasses sample preparation (fixation, delipidation, and refractive index matching), high-resolution lightsheet microscopy, and tailored image analysis (e.g., cell counting, neur
The content above was translated by Ai
Founded Year
2020
Unified Business No.
83761687
Status
Active
Number of Employees
0
Total Paid-in
Capital
86,364,645 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Nebulum Technologies, based in Taipei, is a pioneering bio-imaging startup that specializes in 3D whole-tissue imaging and high-precision data analytics. Using proprietary tissue-clearing, immunolabeling, and lightsheet microscopy techniques, the company delivers continuous, high-fidelity three-dimensional images of biological tissues to research institutions, pharmaceutical companies, and clinical diagnosticians — accelerating progress in precision medicine and biomedical research.
The content above was translated by Ai
